This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AGA Research Foundation Receives $200K Gift From Shire Pharmaceuticals

BETHESDA, Md., April 23, 2013 /PRNewswire-USNewswire/ -- The American Gastroenterological Association (AGA) Research Foundation is pleased to welcome Shire Pharmaceuticals as a supporter of the foundation's endowment.

The AGA Research Foundation provides research grants to young investigators in gastroenterology and hepatology.  The foundation's grants transform young researchers' lives by encouraging them to embark on and continue careers in research. Many ultimately make discoveries that improve patient care.

"Young scientists funded by the AGA Research Foundation are working to improve our understanding of the pathogenesis of gastrointestinal and liver diseases. AGA applauds Shire's support of these young researchers, who hold the keys to the patient care improvements of the future," said Nicholas F. LaRusso, MD, AGAF, chair of the AGA Research Foundation.

Shire Pharmaceuticals' $200,000 gift to the AGA Research Foundation endowment will help ensure that researchers have the tools they need to discover ways to better diagnose, treat and cure digestive diseases. Dedicated to enabling people with life-altering conditions to lead better lives, Shire develops and provides healthcare in the areas of behavioral health and gastro-intestinal (GI) conditions, rare diseases, and regenerative medicine, as well as other symptomatic conditions treated by specialist physicians.

"Shire's support of the AGA Research Foundation reflects our long-standing commitment to fostering innovation to benefit GI patients," said Shire Senior Vice President Roger Adsett, who leads the company's GI business.  "As a leader in GI health, we are dedicated to finding the future of GI and are proud to assist those who are seeking next-generation solutions."

Many breakthroughs have been achieved through gastroenterological and hepatological research over the past century, forming the basis of the modern medical practice. The AGA Research Foundation is working to continue this tradition of discovery and ultimately improve the lives of patients with digestive diseases.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,745.98 -5.41 -0.03%
S&P 500 2,108.63 +0.06 0.00%
NASDAQ 5,128.7850 +17.0520 0.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs